Best TWAS P=3.71e-20 · Best GWAS P=9.95e-18 conditioned to 5.7e-64
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | FCRLB | 0.24 | 0.08 | bslmm | 499 | 0.19 | 1.7e-22 | -4.46 | 6.8 | 8.0e-12 | -0.15 | 1.00 | 0.00 | TRUE |
2 | GTEx | Adipose Subcutaneous | PPOX | 0.15 | 0.02 | enet | 34 | 0.03 | 9.4e-04 | -6.13 | 5.5 | 4.8e-08 | 0.01 | 0.38 | 0.02 | FALSE |
3 | GTEx | Adipose Subcutaneous | NIT1 | 0.16 | 0.06 | enet | 36 | 0.07 | 1.7e-06 | -6.38 | 6.2 | 4.7e-10 | -0.11 | 0.91 | 0.02 | FALSE |
4 | GTEx | Adipose Subcutaneous | B4GALT3 | 0.21 | 0.05 | enet | 23 | 0.11 | 1.6e-09 | 3.81 | 6.4 | 2.0e-10 | 0.01 | 0.90 | 0.01 | FALSE |
5 | GTEx | Adipose Subcutaneous | NDUFS2 | 0.06 | 0.09 | lasso | 4 | 0.07 | 2.0e-06 | -5.65 | 6.6 | 3.9e-11 | -0.08 | 0.89 | 0.00 | TRUE |
6 | GTEx | Adipose Subcutaneous | FCGR2C | 0.25 | 0.16 | lasso | 5 | 0.14 | 4.1e-11 | -5.69 | 5.5 | 3.6e-08 | -0.39 | 1.00 | 0.00 | FALSE |
7 | GTEx | Artery Tibial | FCGR2C | 0.17 | 0.03 | enet | 30 | 0.06 | 2.5e-05 | -5.65 | 5.3 | 1.5e-07 | -0.46 | 0.79 | 0.03 | FALSE |
8 | GTEx | Brain Hippocampus | FCRLB | 0.26 | 0.06 | lasso | 4 | 0.06 | 1.3e-02 | -5.41 | 6.2 | 5.4e-10 | -0.12 | 0.07 | 0.20 | FALSE |
9 | GTEx | Breast Mammary Tissue | HSPA7 | 0.17 | 0.08 | lasso | 4 | 0.12 | 7.7e-07 | -5.69 | 5.7 | 1.5e-08 | -0.38 | 0.91 | 0.00 | FALSE |
10 | GTEx | Breast Mammary Tissue | FCGR2C | 0.15 | 0.13 | lasso | 2 | 0.09 | 2.1e-05 | -5.69 | 5.7 | 1.5e-08 | -0.39 | 0.75 | 0.01 | FALSE |
11 | GTEx | Cells Transformed fibroblasts | B4GALT3 | 0.31 | 0.28 | enet | 16 | 0.30 | 2.0e-22 | 3.81 | 5.8 | 4.9e-09 | -0.08 | 1.00 | 0.00 | FALSE |
12 | GTEx | Cells Transformed fibroblasts | NDUFS2 | 0.11 | 0.07 | lasso | 3 | 0.10 | 1.2e-07 | -6.13 | 5.8 | 5.1e-09 | -0.03 | 0.64 | 0.02 | FALSE |
13 | GTEx | Colon Transverse | NIT1 | 0.17 | 0.10 | enet | 8 | 0.13 | 1.1e-06 | -6.52 | 5.3 | 9.5e-08 | -0.03 | 0.77 | 0.01 | FALSE |
14 | GTEx | Muscle Skeletal | FCGR2C | 0.12 | 0.05 | lasso | 4 | 0.04 | 5.2e-05 | -5.69 | 5.2 | 2.2e-07 | -0.38 | 0.40 | 0.04 | FALSE |
15 | GTEx | Nerve Tibial | PPOX | 0.25 | 0.07 | enet | 43 | 0.15 | 6.7e-11 | -6.52 | 7.1 | 1.5e-12 | 0.15 | 0.94 | 0.00 | TRUE |
16 | GTEx | Testis | ATF6 | 0.23 | 0.08 | lasso | 6 | 0.05 | 3.3e-03 | 5.87 | -5.6 | 1.9e-08 | 0.12 | 0.21 | 0.05 | TRUE |
17 | GTEx | Thyroid | PPOX | 0.12 | 0.00 | lasso | 6 | 0.01 | 6.1e-02 | -4.18 | 5.5 | 5.0e-08 | 0.00 | 0.04 | 0.04 | TRUE |
18 | GTEx | Whole Blood | FCGR2B | 0.26 | 0.10 | enet | 35 | 0.14 | 9.4e-13 | -5.61 | -6.3 | 2.4e-10 | 0.51 | 0.98 | 0.02 | FALSE |
19 | METSIM | Adipose | B4GALT3 | 0.05 | 0.03 | lasso | 7 | 0.04 | 2.7e-06 | -5.51 | 5.8 | 8.1e-09 | -0.09 | 0.96 | 0.00 | FALSE |
20 | METSIM | Adipose | FCER1G | 0.15 | 0.11 | enet | 15 | 0.12 | 6.3e-17 | 4.14 | 5.4 | 6.8e-08 | -0.06 | 1.00 | 0.00 | FALSE |
21 | METSIM | Adipose | FCGR2C | 0.16 | 0.08 | enet | 27 | 0.10 | 3.3e-15 | 2.83 | 5.6 | 2.7e-08 | -0.60 | 0.02 | 0.98 | FALSE |
22 | METSIM | Adipose | NDUFS2 | 0.10 | 0.01 | blup | 393 | 0.05 | 1.3e-07 | -2.68 | 6.3 | 3.1e-10 | -0.19 | 0.96 | 0.00 | FALSE |
23 | NTR | Blood | FCGR2B | 0.25 | 0.06 | enet | 88 | 0.18 | 7.9e-57 | -8.57 | -7.7 | 2.0e-14 | 0.60 | 0.00 | 1.00 | FALSE |
24 | NTR | Blood | MPZ | 0.03 | 0.00 | blup | 417 | 0.00 | 4.8e-02 | 2.46 | -5.8 | 6.0e-09 | 0.13 | 0.13 | 0.05 | FALSE |
25 | YFS | Blood | B4GALT3 | 0.04 | 0.02 | lasso | 5 | 0.02 | 7.3e-08 | -5.51 | 6.5 | 7.5e-11 | -0.12 | 0.05 | 0.95 | FALSE |
26 | YFS | Blood | FCGR2B | 0.54 | 0.21 | enet | 101 | 0.38 | 9.1e-133 | -5.61 | -7.2 | 7.8e-13 | 0.53 | 0.98 | 0.02 | FALSE |
27 | The Cancer Genome Atlas | Breast Invasive Carcinoma | FCER1G | 0.03 | 0.02 | lasso | 4 | 0.03 | 1.8e-06 | -5.55 | 6.2 | 7.1e-10 | -0.10 | 0.15 | 0.84 | FALSE |
28 | The Cancer Genome Atlas | Breast Invasive Carcinoma | HSPA7 | 0.04 | 0.02 | enet | 3 | 0.03 | 2.5e-06 | -8.57 | 9.1 | 6.3e-20 | -0.88 | 0.00 | 1.00 | FALSE |
29 | The Cancer Genome Atlas | Colon Adenocarcinoma | HSPA7 | 0.06 | 0.03 | lasso | 2 | 0.02 | 2.7e-02 | -8.57 | 8.7 | 4.2e-18 | -1.00 | 0.00 | 0.84 | FALSE |
30 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | DUSP12 | 0.05 | 0.03 | lasso | 4 | 0.03 | 5.4e-04 | -6.22 | 5.6 | 1.7e-08 | -0.25 | 0.02 | 0.70 | FALSE |
31 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | HSPA7 | 0.03 | 0.02 | lasso | 1 | 0.01 | 8.7e-03 | -8.57 | 8.6 | 1.0e-17 | -1.00 | 0.00 | 0.84 | FALSE |
32 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | FCER1G | 0.04 | 0.00 | enet | 11 | 0.02 | 4.2e-03 | -6.52 | 6.6 | 5.3e-11 | 0.00 | 0.01 | 0.90 | FALSE |
33 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | FCGR2C | 0.04 | 0.03 | lasso | 1 | 0.03 | 2.1e-04 | -8.57 | -8.6 | 1.0e-17 | 1.00 | 0.00 | 0.99 | FALSE |
34 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | HSPA7 | 0.02 | 0.02 | lasso | 1 | 0.01 | 1.2e-02 | -8.57 | 8.6 | 1.0e-17 | -1.00 | 0.00 | 0.87 | FALSE |
35 | The Cancer Genome Atlas | Brain Lower Grade Glioma | DEDD | 0.02 | 0.03 | lasso | 1 | 0.03 | 4.2e-04 | -6.52 | 6.5 | 7.2e-11 | -0.05 | 0.01 | 0.96 | FALSE |
36 | The Cancer Genome Atlas | Brain Lower Grade Glioma | FCER1G | 0.06 | 0.02 | blup | 71 | 0.05 | 2.7e-06 | -5.65 | 6.2 | 6.3e-10 | -0.09 | 0.08 | 0.82 | FALSE |
37 | The Cancer Genome Atlas | Brain Lower Grade Glioma | FCRLB | 0.09 | 0.00 | blup | 93 | 0.03 | 2.0e-04 | -4.80 | 7.2 | 5.5e-13 | -0.22 | 0.13 | 0.06 | FALSE |
38 | The Cancer Genome Atlas | Brain Lower Grade Glioma | NR1I3 | 0.03 | 0.04 | lasso | 2 | 0.02 | 9.1e-04 | -5.15 | 5.2 | 2.6e-07 | 0.01 | 0.40 | 0.05 | FALSE |
39 | The Cancer Genome Atlas | Lung Adenocarcinoma | HSPA7 | 0.08 | 0.02 | enet | 3 | 0.05 | 9.2e-07 | -0.72 | 7.3 | 2.6e-13 | -0.53 | 0.00 | 0.53 | FALSE |
40 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | FCER1G | 0.04 | 0.01 | blup | 72 | 0.01 | 7.7e-03 | 3.76 | 5.7 | 1.2e-08 | -0.09 | 0.07 | 0.07 | FALSE |
41 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | HSPA7 | 0.05 | 0.00 | enet | 3 | 0.02 | 2.7e-02 | -8.57 | 8.3 | 1.4e-16 | -0.72 | 0.00 | 0.57 | FALSE |
42 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | HSPA7 | 0.23 | 0.13 | enet | 3 | 0.14 | 1.5e-06 | -8.57 | 9.2 | 3.7e-20 | -0.95 | 0.00 | 1.00 | TRUE |
43 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | TOMM40L | 0.16 | 0.07 | lasso | 3 | 0.05 | 6.0e-03 | -6.13 | -6.2 | 7.2e-10 | -0.03 | 0.01 | 0.82 | FALSE |
44 | The Cancer Genome Atlas | Prostate Adenocarcinoma | FCER1G | 0.10 | 0.07 | blup | 70 | 0.06 | 8.7e-07 | -6.52 | 6.3 | 3.2e-10 | 0.01 | 0.00 | 1.00 | FALSE |
45 | The Cancer Genome Atlas | Prostate Adenocarcinoma | HSPA7 | 0.06 | 0.01 | enet | 3 | 0.04 | 1.1e-04 | -8.57 | 7.9 | 3.1e-15 | -0.61 | 0.00 | 0.50 | FALSE |
46 | The Cancer Genome Atlas | Soft Tissue Sarcoma | FCER1G | 0.15 | 0.08 | blup | 70 | 0.09 | 3.3e-06 | -2.68 | 5.4 | 5.8e-08 | -0.05 | 0.02 | 0.97 | FALSE |
47 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | FCGR3B | 0.36 | 0.00 | enet | 5 | 0.12 | 4.0e-05 | -8.57 | -7.4 | 1.2e-13 | 0.58 | 0.00 | 0.58 | FALSE |